Spots Global Cancer Trial Database for sitagliptin
Every month we try and update this database with for sitagliptin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | NCT02060383 | Cushing's Disea... Acromegaly | Pasireotide s.c... Sitagliptin Liraglutide Insulin Pasireotide LAR Metformin | 18 Years - | Novartis | |
| The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome | NCT02122380 | Polycystic Ovar... | Sitagliptin Placebo | 18 Years - 40 Years | Vanderbilt University Medical Center | |
| Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients | NCT05947825 | PDAC - Pancreat... | Combination of ... | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome | NCT03122041 | PCOS | Sitagliptin Lifestyle inter... | 18 Years - 55 Years | University Medical Centre Ljubljana | |
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | NCT02060383 | Cushing's Disea... Acromegaly | Pasireotide s.c... Sitagliptin Liraglutide Insulin Pasireotide LAR Metformin | 18 Years - | Novartis | |
| High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD | NCT05895201 | Bone Marrow Tra... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myelomo... | Sitagliptin Bortezomib Cyclophosphamid... | 18 Years - | Indiana University | |
| High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD | NCT05895201 | Bone Marrow Tra... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myelomo... | Sitagliptin Bortezomib Cyclophosphamid... | 18 Years - | Indiana University | |
| A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection | NCT02650427 | Hepato Carcinom... | Sitagliptin | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
| Sitagliptin Umbilical Cord Blood Transplant Study | NCT00862719 | Leukemia, Myelo... Acute Lymphobla... Myelodysplasia Leukemia, Myelo... Lymphoma, Non-H... | Sitagliptin | 18 Years - 59 Years | Indiana University | |
| Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients | NCT05972928 | Polycystic Ovar... | Sitagliptin 100... | 20 Years - 40 Years | Beni-Suef University | |
| High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD | NCT05895201 | Bone Marrow Tra... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myelomo... | Sitagliptin Bortezomib Cyclophosphamid... | 18 Years - | Indiana University | |
| A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection | NCT02650427 | Hepato Carcinom... | Sitagliptin | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
| Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients | NCT05947825 | PDAC - Pancreat... | Combination of ... | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant | NCT01720264 | Acute Myeloid L... Acute Lymphoid ... Hematopoetic My... Leukemia, Myelo... Lymphoma, Non-H... | Sitagliptin | 18 Years - 60 Years | Indiana University | |
| The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome | NCT02122380 | Polycystic Ovar... | Sitagliptin Placebo | 18 Years - 40 Years | Vanderbilt University Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
